1. OP0164 BLISS-LN: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS. (2nd June 2020) Authors: Furie, R.; Rovin, B. H.; Houssiau, F.; Amoura, Z.; Santiago, M.; Contreras, G.; Malvar, A.; Mok, C. C.; Saxena, A.; Yu, X.; Teng, Y. K. O.; Barnett, C.; Burriss, S.; Green, Y.; Ji, B.; Kleoudis, C.; Roth, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0253 A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritis. (12th June 2018) Authors: Furie, R.; Dooley, M.A.; Wofsy, D.; Takeuchi, T.; Malvar, A.; Doria, A.; Romero-Díaz, J.; Chan, T.M.; Elegbe, A.; Appel, G.B.; Jayne, D.; Maldonado, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗